Belgium, Mont-Saint-Guibert, 13 January 2026 – Cellistic, a global leader in allogeneic iPSC-derived cell therapy manufacturing, today announced the launch of three new iPSC-derived GMP cell therapy ...
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in Parkinson’s disease, following compelling Phase I clinical data | iRegene’s ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...
Prior to 2006, the scientific consensus was that cell differentiation was a one-way street: once mature, cells could not be returned to their initial embryonic-like state, having lost the potential to ...
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results